| 1 |
31896438 | ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients. | 2020 Feb |
7 |
| 2 |
32790988 | [Pharmacogenetic aspects of the dopaminergic system in clozapine pharmacodynamics]. | 2020 |
1 |
| 3 |
21332319 | Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response. | 2011 Feb |
1 |
| 4 |
18449897 | Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. | 2009 Jan 5 |
2 |
| 5 |
14681904 | Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. | 2004 Jan 1 |
1 |
| 6 |
10647091 | Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients. | 1999 Dec |
1 |
| 7 |
9491816 | The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. | 1998 Jan |
1 |
| 8 |
8996810 | 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. | 1996 Dec |
1 |
| 9 |
1349574 | The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. | 1992 May |
1 |